POLAREAN IMAG.LS-00037
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent ind… Read more
POLAREAN IMAG.LS-00037 (8ZF) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, POLAREAN IMAG.LS-00037 (8ZF) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
POLAREAN IMAG.LS-00037 - Net Assets Trend (None–None)
This chart illustrates how POLAREAN IMAG.LS-00037's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for POLAREAN IMAG.LS-00037 (None–None)
The table below shows the annual net assets of POLAREAN IMAG.LS-00037 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to POLAREAN IMAG.LS-00037's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
POLAREAN IMAG.LS-00037 Competitors by Market Cap
The table below lists competitors of POLAREAN IMAG.LS-00037 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Checkin.com Group AB
ST:CHECK
|
$1.07 Million |
|
STATE STREET (ZYA.SG)
STU:ZYA
|
$1.07 Million |
|
SANMINA (SAYN.SG)
STU:SAYN
|
$1.07 Million |
|
Sektkellerei J.Oppmann AG
MU:1SK
|
$1.08 Million |
|
Smtrack Bhd
KLSE:0169
|
$1.07 Million |
|
New World Resources Ltd
AU:NWC
|
$1.07 Million |
|
EMERSON ELECTRIC - Dusseldorf Stock Exchang
DU:EMR
|
$1.07 Million |
|
SUNKWAN P.G. DL-000001
F:5YQ
|
$1.07 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in POLAREAN IMAG.LS-00037's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares POLAREAN IMAG.LS-00037's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently POLAREAN IMAG.LS-00037 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares POLAREAN IMAG.LS-00037's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| POLAREAN IMAG.LS-00037 (8ZF) | €- | N/A | N/A | $1.07 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |